--- title: "AstraZeneca and Oracle Partner on AI for Clinical Research" publication: "MediaBias News" url: "https://mediabias.news/tech/astrazeneca-and-oracle-partner-on-ai-for-clinical-research" api: "https://mediabias.news/api/v1/stories/astrazeneca-and-oracle-partner-on-ai-for-clinical-research" markdown: "https://mediabias.news/tech/astrazeneca-and-oracle-partner-on-ai-for-clinical-research.md" audio: "https://mediabias.news/api/audio/astrazeneca-and-oracle-partner-on-ai-for-clinical-research" category: "Science & Tech" area: "Middle East" published: "2026-10-20T10:45:52.071Z" source_reported: "2026-10-20T10:11:00.000Z" updated: "2026-10-20T10:45:52.071Z" trust_score: 42 critic_score: 61 hype_score: 20 assessment_type: "coverage-and-source-reporting-analysis" fact_check_status: "not-performed" coverage_measured: "2026-10-20T12:54:47.217Z" --- # AstraZeneca and Oracle Partner on AI for Clinical Research *The collaboration aims to speed up patient identification and safety monitoring in drug development.* **Scores for the source reporting** (0-100, assessing the original journalism this article was written from, not this write-up): - Trust 42 of 100, higher is better. The central claim is attributed to AstraZeneca and Oracle, with one full report and multiple digests. - Craft 61 of 100, higher is better. The reporting clearly separates facts from comment and provides specific details about the collaboration. - Hype 20 of 100, lower is better. The language used is neutral and proportionate, with no sensationalism or manufactured urgency. Scored by MediaBias News; method at https://mediabias.news/methodology. **The short version** - AstraZeneca and Oracle are collaborating to use AI and real-world data to improve clinical research. - The partnership aims to identify eligible patients for clinical trials more efficiently and monitor safety signals. - Initial research will concentrate on cancer, cardiovascular, respiratory, immunology, and rare diseases. - The first project will support hypertension research in Abu Dhabi, in conjunction with M42. AstraZeneca and Oracle have announced a partnership to integrate artificial intelligence and real-world data into clinical research processes. The collaboration is designed to accelerate the identification of patients suitable for clinical trials and to enhance the monitoring of safety indicators. This initiative is intended to streamline drug development and improve patient care pathways. The initial phase of this partnership will concentrate on therapeutic areas including cancer, cardiovascular conditions, respiratory illnesses, immunology, and rare diseases. The companies stated that the collaboration will combine AstraZeneca's expertise in drug development with Oracle's capabilities in AI and healthcare data. Patient recruitment is identified as a significant bottleneck in clinical research, often leading to extended trial timelines and increased development costs. The first project under this alliance will focus on hypertension research and will take place in Abu Dhabi. This initiative is being undertaken in partnership with M42, a healthcare firm based in the UAE. AstraZeneca has stated its ambition to expand its medicine portfolio and reach over $80 billion in annual revenue by 2030, while also addressing industry challenges in drug development. ## Coverage comparison Reports from Channel News Asia, Reuters, WTVB, PressNewsAgency, and Waterloo Cedar Falls Courier stated that AstraZeneca is working with Oracle to use AI and real-world data to identify eligible patients for clinical trials and monitor safety signals. Channel News Asia and PressNewsAgency also noted that the collaboration combines AstraZeneca's drug development expertise with Oracle's AI and healthcare data capabilities. Channel News Asia additionally reported that patient recruitment is a major challenge in clinical research, often extending trial timelines and increasing costs. It also mentioned that incorrect trial designs have previously affected AstraZeneca, citing delays with its breast cancer drug and a nerve disorder treatment failure. The outlet further stated AstraZeneca's goal to expand its medicine portfolio and target over $80 billion in annual revenue by 2030. Reports from Herald & Review, Lincoln Journal Star, NE Iowa Publishing, PR Newswire, and The Bay City Tribune focused on the collaboration connecting AstraZeneca's scientific and therapeutic expertise with Oracle's real-world data, cloud, AI, and clinical capabilities. These reports stated the aim is to accelerate clinical research and integrate evidence-driven insights into care workflows to improve patient care. PR Newswire specifically mentioned Oracle's announcement of an agreement with AstraZeneca to explore how AI and real-world data can assist clinicians in identifying eligible patients. The Hindu Business Line and The Bay City Tribune reported that AstraZeneca is teaming up with Oracle to use AI and real-world data for patient matching, safety monitoring, and faster clinical trials. The Bay City Tribune also included that the collaboration connects AstraZeneca's scientific and therapeutic expertise with Oracle's real-world data, cloud, AI, and clinical capabilities to accelerate clinical research and improve patient care. ## What the coverage left out None of the right-rated digests mention the specific focus on cancer, cardiovascular, respiratory, immunology, and rare diseases for the initial work. The right-rated digests also do not mention the specific challenges in clinical research such as patient recruitment delays and incorrect trial designs, which were detailed in the Channel News Asia report. ## Who covered it Shares of the 14 covering outlets with a published leaning rating: - Left: 14% (2) - Centre: 65% (9) - Right: 21% (3) 7 of 21 covering outlets carried no usable leaning rating and were excluded from those percentages. Coverage measured 2026-10-20T12:54:47.217Z. **Coverage watch:** developing. Checked 9 times; 0 checks found a material change. Most recently checked 2026-10-20T13:00:25.181Z. ## How the sides framed it ### Left - The left-rated report from CNBC highlighted that AstraZeneca and Oracle are launching their first global AI program in Abu Dhabi, according to AstraZeneca's CEO Pascal Soriot. The report stated the companies are teaming up on AI with the aim of speeding up clinical trials and improving patient care pathways, with the initial programme set for Abu Dhabi in partnership with M42. CNBC's Dan Murphy spoke with Soriot live from the Future Health Summit in Abu Dhabi. ### Centre - The centre-rated reports led on AstraZeneca's partnership with Oracle to use AI and real-world data for clinical trials. Channel News Asia, Reuters, WTVB, and PressNewsAgency reported that the collaboration aims to identify eligible patients and monitor safety signals. Channel News Asia, in its full report, also detailed that patient recruitment is a significant challenge in clinical research, often extending trial timelines and increasing development costs. It further noted that incorrect trial designs have previously impacted AstraZeneca, mentioning delays with its breast cancer drug and a nerve disorder treatment failure. This report also included AstraZeneca's business goals, such as expanding its medicine portfolio to target over $80 billion in annual revenue by 2030. Reports from Herald & Review, Lincoln Journal Star, NE Iowa Publishing, Waterloo Cedar Falls Courier, and PR Newswire focused on the collaboration's aim to connect AstraZeneca's expertise with Oracle's data and AI capabilities to accelerate research and improve patient care. The first project in Abu Dhabi supporting hypertension research with M42 was mentioned by Channel News Asia and CNBC (rated left). ### Right - The right-rated reports from The Hindu Business Line and The Bay City Tribune stated that AstraZeneca is partnering with Oracle to use AI and real-world data for patient matching, safety monitoring, and faster clinical trials. The Bay City Tribune also mentioned that the collaboration connects AstraZeneca's scientific and therapeutic expertise with Oracle's real-world data, cloud, AI, and clinical capabilities to accelerate clinical research and improve patient care. ## Factuality profile of the covering outlets These are published factuality ratings of the outlets, not a verdict on whether this story or its claims are true. - mixed: 1 - high: 7 - unknown: 7 - veryHigh: 6 ## Verification scope This page compares coverage and scores the source reporting. It is not a ClaimReview verdict on whether the underlying event or claim is true. ## Original reporting this was written from - [DistilINFO Publications](https://distilinfo.com/2026/10/20/oracle-astrazeneca-partnership) — Oracle, AstraZeneca Target Trial Recruitment With AI 2026 - [EuropaWire.eu](https://news.europawire.eu/astrazeneca-and-oracle-partner-on-ai-driven-clinical-trial-optimisation-and-patient-care/eu-press-release/2026/10/20/14/00/04/183571) — AstraZeneca and Oracle partner on AI-driven clinical trial optimisation and patient care - [Seeking Alpha](https://seekingalpha.com/news/4654517-astrazeneca-oracle-strike-ai-collaboration?feed_item_type=news) — AstraZeneca and Oracle strike AI collaboration to speed up clinical trials - [DiarioBitcoin](https://diariobitcoin.com/tecnologia/astrazeneca-y-oracle-exploraran-usar-ia-para-encontrar-pacientes-para-ensayos) — AstraZeneca and Oracle Will Explore Using AI to Find Patients for Trials - [Pharmaphorum](https://pharmaphorum.com/news/az-and-oracle-team-ai-platform-clinical-trials) — AZ and Oracle team up on AI platform for clinical trials - [دیجیاتو](https://digiato.com/artificial-intelligence/astrazeneca-oracle-ai-clinical-trials) — AstraZeneca and Oracle Are Transforming the Clinical Trials Process with Artificial Intelligence - [TNW](https://thenextweb.com/news/astrazeneca-oracle-ai-drug-trials) — AstraZeneca and Oracle team up on AI to find patients for drug trials - [Reuters](https://reuters.com/legal/litigation/astrazeneca-partners-with-oracle-ai-driven-clinical-trials-2026-10-20) — AstraZeneca partners with Oracle for AI-driven clinical trials - [Unknown](https://snabusiness.com/article/1899410-%D8%A3%D8%A8%D9%88%D8%B8%D8%A8%D9%8A-%D8%AA%D9%82%D9%88%D8%AF-%D9%85%D8%B4%D8%A7%D8%B1%D9%8A%D8%B9-%D8%A7%D9%84%D8%AA%D8%AD%D8%A7%D9%84%D9%81-%D8%A3%D8%B3%D8%AA%D8%B1%D8%A7%D8%B2%D9%8A%D9%86%D9%8A%D9%83%D8%A7-%D9%88%D8%A3%D9%88%D8%B1%D8%A7%D9%83%D9%84) — Abu Dhabi Leads the First Astrasnica-Orakel Alliance. - [Cryptopolitan](https://cryptopolitan.com/oracle-astrazeneca-ai-deal-clinical-trials) — Oracle and AstraZeneca sign AI deal to speed up clinical trials - [The Hindu Business Line](https://thehindubusinessline.com/info-tech/astrazeneca-partners-with-oracle-for-ai-driven-clinical-trials/article71603695.ece) — AstraZeneca partners with Oracle for AI-driven clinical trials - [Channel News Asia](https://channelnewsasia.com/business/astrazeneca-partners-oracle-ai-driven-clinical-trials-6474856) — AstraZeneca partners with Oracle for AI-driven clinical trials - [WTVB](https://wtvbam.com/2026/10/20/astrazeneca-partners-with-oracle-for-ai-driven-clinical-trials) — AstraZeneca partners with Oracle for AI-driven clinical trials - [PressNewsAgency](https://pressnewsagency.org/astrazeneca-partners-with-oracle-for-ai-driven-clinical-trials) — AstraZeneca partners with Oracle for AI-driven clinical trials - [CNBC](https://cnbc.com/video/2026/10/20/astrazeneca-oracle-launch-first-global-ai-program-in-abu-dhabi-ceo.html) — AstraZeneca, Oracle to launch their first global AI program in Abu Dhabi: CEO - [Herald & Review](https://herald-review.com/online_features/press_releases/article_b4595530-f6fe-5a9f-838d-cc71d7a014cc.html) — Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation - [Lincoln Journal Star](https://journalstar.com/online_features/press_releases/article_274a6de3-c7c6-5a3b-b398-aa5e4b131a0b.html) — Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation - [NE Iowa Publishing](https://communitynewspapergroup.com/online_features/press_releases/oracle-and-astrazeneca-partner-to-advance-ai-enabled-healthcare-innovation/article_fdad384c-a920-5771-99b3-aa03c2eed3cc.html) — Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation - [PR Newswire](https://prnewswire.com/news-releases/oracle-and-astrazeneca-partner-to-advance-ai-enabled-healthcare-innovation-302913441.html) — Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation - [The Bay City Tribune](https://baycitytribune.com/online_features/press_releases/oracle-and-astrazeneca-partner-to-advance-ai-enabled-healthcare-innovation/article_11655435-251b-562a-82a2-abd22d174565.html) — Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation - [Waterloo Cedar Falls Courier](https://wcfcourier.com/online_features/press_releases/article_74e61bf8-1eb2-5be2-ba09-4e2eb33bd5a0.html) — Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation ## Questions **What is the main goal of the AstraZeneca and Oracle partnership?** The partnership aims to improve clinical research by using artificial intelligence and real-world data. This includes identifying eligible patients for clinical trials more efficiently and monitoring safety signals to speed up the drug development process. **Which disease areas will the initial work focus on?** The initial phase of the collaboration will concentrate on key therapeutic areas such as cancer, cardiovascular diseases, respiratory illnesses, immunology, and rare diseases. **Where will the first project under this alliance take place?** The first project will support hypertension research and is set to take place in Abu Dhabi. This initiative is being conducted in partnership with M42, a healthcare firm based in the UAE. --- MediaBias News — https://mediabias.news. Reproduced from https://mediabias.news/tech/astrazeneca-and-oracle-partner-on-ai-for-clinical-research. Please cite as: MediaBias News, "AstraZeneca and Oracle Partner on AI for Clinical Research", https://mediabias.news/tech/astrazeneca-and-oracle-partner-on-ai-for-clinical-research